Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Alcobendas

21 clinical trials in Alcobendas, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Alcobendas at a glance
21
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

21 trials in Alcobendas

Open in trial search

Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

Eczema nummular

Recruiting

A study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Almirall S.A.

Gouty arthritis

Recruiting

A study comparing dotinurad and allopurinol for lowering uric acid levels in adults with gout and high uric acid in the blood.

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Allopurinol
  • Sponsor:Crystalys Therapeutics Inc.

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC

Evaluating Different Durations of Antibiotic Treatment for Respiratory Tract Infections and Rhinosinusitis in Adults Receiving Beta-lactam Antibiotics

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Institut Universitari D Investigacio En Atencion Primaria Jordi Gol

Bullous impetigo+3

Recruiting

Comparing two forms of mupirocin (gel and ointment) for treating impetigo in children: a study of different dosing schedules

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Sponsor:Laboratorios Ojer Pharma S.L.

Study on Long-Term Safety of Cenerimod for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cenerimod
  • Sponsor:Viatris Innovation GmbH

Immunisation+3

Not yet recruiting

SARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
  • Sponsor:Sanofi Pasteur Inc.

Systemic lupus erythematosus+1

Not yet recruiting

Randomized Placebo‑Controlled Trial of Cenerimod for Efficacy and Safety in Adults with Systemic Lupus Erythematosus and Active Lupus Nephritis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cenerimod
  • Sponsor:Viatris Innovation GmbH

Psoriatic arthropathy

Not yet recruiting

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Psoriatic arthropathy

Not yet recruiting

A study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Janssen Cilag International

Psoriatic arthropathy

Not recruiting

Study of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:MoonLake Immunotherapeutics AG

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Alcobendas

What the registry says about research in the country

01 Rheumatology Studies

Multiple clinical investigations focusing on psoriatic arthritis treatments, including studies of novel therapeutics like zasocitinib and sonelokimab for patients with varying treatment histories.

  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus

Research aims to evaluate treatment effectiveness in both biologic-naive patients and those with inadequate response to previous therapies.

02 Dermatology and Pain Management

Innovative research exploring treatments for atopic dermatitis and chronic pain conditions, with studies evaluating new therapeutic approaches for moderate-to-severe cases.

  • Atopic Dermatitis Studies
  • Chronic Low Back Pain
  • Refractory Chronic Cough

These trials focus on developing targeted treatments for conditions that significantly impact quality of life.

03 Neurological and Cardiovascular Research

Advanced studies targeting Alzheimer's-related agitation and cardiovascular complications in dialysis patients, representing crucial areas of medical need.

  • Alzheimer's Disease Management
  • Cardiovascular Disease in ESKD

Research focuses on innovative treatments for complex medical conditions affecting specific patient populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.